A novel flow cytometric assay for detection of residual disease in patients with B-lymphoblastic leukemia/lymphoma post anti-CD19 therapy. (Q48800056)
Jump to navigation
Jump to search
scientific article published on 6 September 2016
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A novel flow cytometric assay for detection of residual disease in patients with B-lymphoblastic leukemia/lymphoma post anti-CD19 therapy. |
scientific article published on 6 September 2016 |
Statements
1 reference
A novel flow cytometric assay for detection of residual disease in patients with B-lymphoblastic leukemia/lymphoma post anti-CD19 therapy. (English)
1 reference
Sindhu Cherian
1 reference
Valerie Miller
1 reference
Vivian McCullouch
1 reference
Katy Dougherty
1 reference
Jonathan R Fromm
1 reference
Brent L Wood
1 reference
6 September 2016
1 reference
94
1 reference
1
1 reference
112-120
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference